Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced

BusinesswireApr 9 08:30 ET

30 Countries With the Lowest Depression Rates

Yahoo FinanceMar 26 06:24 ET

This Overlooked Corner of Women's Health Could Be a $350 Billion Market Opportunity

Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.

CNBCMar 15 14:33 ET

Vistagen to Present at Stifel 2024 Virtual CNS Days

Vistagen (NASDAQ:VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management

BusinesswireMar 11 08:30 ET

Vistagen to Present at TD Cowen 44th Annual Health Care Conference

Vistagen (NASDAQ:VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management

BusinesswireFeb 28 08:30 ET

10 Health Care Stocks Whale Activity In Today's Session

Traders often look for circumstances when the market estimation of an option diverges away from its normal worth.

BenzingaFeb 19 12:35 ET